In-vitro Susceptibility Testing of Dermatophytes Isolated in Delhi (India) Against Five Antifungal Drugs
Main Article Content
Abstract
Background: Over the past few decades, cases of dermatophytosis have been on the rise. Recently, the introduction of newer, less toxic antifungal drugs has improved treatment options. However, the prolonged use of antifungals has led to the emergence of acquired resistance among strains that were previously susceptible, as well as an increase in infections caused by less common species. This scenario underscores the growing need for rapid and accurate antifungal susceptibility testing methods. In this study, antifungal susceptibility was assessed using the in-vitro micro broth dilution method, adhering to the CLSI M38-A guidelines
Methods: 60 clinical specimens were collected from Nail and skin of the patients of dermatophytosis from Delhi (India). Minimal inhibitory concentration (MIC) was performed in microtiter plates with U-bottom and incubated at 35° C. Reading were taken after 48 & 96 hrs of incubation for Trichophyton mentagrophytes and Trichophyton rubrum, against 5 antifungal drugs namely fluconazole, itraconazole (triazoles), griseofulvin, terbinafine and Luliconazole.
Results: Most of the dermatophytes had uniform patterns of susceptibility to the antifungal agents tested. Low MIC values as 0.03μg/mL were found for 33.3%, 31.6% and 15% of isolates for itraconazole and terbinafine, respectively.
Conclusion: In conclusion, it may be useful to undertake periodical screening programs to detect the antifungal susceptibility of newer antifungal agents.
Downloads
Article Details
Copyright (c) 2024 Shyama Datt, Thakur Datt; N.P Singh
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
CLSI Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. Clin Lab Stand Inst. 2008;28:52. [Google Scholar]
CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard – Document M38-A2. 2nd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
Coelho LM, Aquino-Ferreira R, Maffei CM, Martinez-Rossi NM. In vitro antifungal drug susceptibilities of dermatophytes microconidia and arthroconidia. Journal of antimicrobial chemotherapy. 2008 Oct 1;62(4):758-61.
Cuenca-Estrella, M., Gomez-Lopez, A., Alastruey-Izquierdo, A., Bernal-Martinez, L., Cuesta, I., Buitrago, M.J. and Rodriguez-Tudela, J.L., 2010. Comparison of the Vitek 2 antifungal susceptibility system with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution reference methods and with the Sensititre YeastOne and Etest techniques for in vitro detection of antifungal resistance in yeast isolates. Journal of clinical microbiology, 48(5), pp.1782-1786.
da Silva Barros ME, de Assis Santos D, Hamdan JS. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). Journal of medical microbiology. 2007 Apr 1;56(4):514-8.
Dabas Y, Xess I, Singh G, Pandey M, Meena S. Molecular identification and antifungal susceptibility patterns of clinical dermatophytes following CLSI and EUCAST guidelines. Journal of Fungi. 2017 Jun;3(2):17.
In vitro antifungal activity of luliconazole against clinical isolates from patients with dermatomycoses. Hiroy asu Koga, Y uri Tsuji, Kazuy oshi Inoue, Kazuo Kanai, Toshiro Majima, Tatsuy a Kasai, Katsuhisa Uchida, Hidey o Y amaguchi.(2006).
Dahl MV, Grando SA. Chronic dermatophytosis: what is special about Trichophyton rubrum?. Advances in dermatology. 1994;9:97-109.
Danew P, Friedrich E, Mannsfeldt HG. Peptidase activity of skin-pathogenic fungi. I. Determination of leucineaminopeptidase, arylamidase, carboxypeptidase and acylase activity in Trichophyton rubrum and Microsporum gypseum. Dermatologische Monatschrift. 1971 Apr;157(4):232.
Davidson, F. D., and D. W. R. Mackenzie. 1984. DNA homology studies in the taxonomy of dermatophytes. J. Med. Vet. Mycol. 2:117–123
Dawson CO, Gentles JC. Perfect stage of Keratinomyces ajelloi. Nature. 1959 May 9;183(4671):1345-6.
de Aguiar Peres NT, Maranhao FA, Rossi A, Martinez-Rossi NM. Dermatophytes: host-pathogen interaction and antifungal resistance. Anais brasileiros de dermatologia. 2010 Sep 1;85(5):657-67.
De Backer MD, Ilyina T, Ma XJ, Vandoninck S, Luyten WH, Bossche HV. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrobial agents and chemotherapy. 2001 Jun 1; 45 (6) : 1660-70.
De Bièvre C, Dauguet C, Nguyen VH, Ibrahim-Granet O. Polymorphism in mitochondrial DNA of several Trichophyton rubrum isolates from clinical specimens. InAnnales de l'Institut Pasteur/Microbiologie 1987 Nov 1 (Vol. 138, No. 6, pp. 719-727). Elsevier Masson.
De Coi N, Feuermann M, Schmid-Siegert E, Băguţ ET, Mignon B, Waridel P, Peter C, Pradervand S, Pagni M, Monod M. RNA Sequencing-Based Genome Reannotation of the Dermatophyte Arthroderma benhamiae and Characterization of Its Secretome and Whole Gene Expression Profile during Infection. MSystems. 2016 Aug 30;1(4):e00036-16.
de Hoog GS, Dukik K, Monod M, Packeu A, Stubbe D, Hendrickx M, Kupsch C, Stielow JB, Freeke J, Göker M, Rezaei-Matehkolaei A. Toward a novel multilocus phylogenetic taxonomy for the dermatophytes. Mycopathologia. 2017 Feb 1;182(1-2):5-31.
Del Aguila R, Montero Gei F, Robles M, Perera‐Ramirez A, Male O. Once‐weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. Clinical and experimental dermatology. 1992 Nov;17(6):402-6.
Del Rosso JQ. The role of topical antifungal therapy for onychomycosis and the emergence of newer agents. The Journal of clinical and aesthetic dermatology. 2014 Jul;7(7):10.
Deng W, Liang P, Zheng Y, Su Z, Gong Z, Chen J, Feng P, Chen J. Differential gene expression in HaCaT cells may account for the various clinical presentation caused by anthropophilic and geophilic dermatophytes infections. Mycoses. 2020 Jan;63(1):21-9.
Denning DW. Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. Journal of antimicrobial chemotherapy. 1991 Jan 1;28(suppl_B):1-6.
Descamps F, Brouta F, Baar D, Losson B, Mignon B, Monod M, Zaugg C. Isolation of a Microsporum canis gene family encoding three subtilisin-like proteases expressed in vivo. Journal of investigative dermatology. 2002 Oct 1;119(4):830-5.
Descamps F, Brouta F, Vermout S, Monod M, Losson B, Mignon B. Recombinant expression and antigenic properties of a 31.5-kDa keratinolytic subtilisin-like serine protease from Microsporum canis. FEMS Immunology & Medical Microbiology. 2003 Aug 1;38(1):29-34.
Descamps FF, Brouta F, Vermout SM, Willame C, Losson BJ, Mignon BR. A recombinant 31.5 kDa keratinase and a crude exo‐antigen from Microsporum canis fail to protect against a homologous experimental infection in guinea pigs. Veterinary dermatology. 2003 Dec;14(6):305-12.
Dhib I, Khammari I, Yaacoub A, Slama FH, Saïd MB, Zemni R, Fathallah A. Relationship between phenotypic and genotypic characteristics of Trichophyton mentagrophytes strains isolated from patients with dermatophytosis. Mycopathologia. 2017 Jun 1;182(5-6):487-93.
Diao Y, Zhao R, Deng X, Leng W, Peng J, Jin Q. Transcriptional profiles of Trichophyton rubrum in response to itraconazole. Medical mycology. 2009 May 1; 47 (3) : 237-47.
Digby W, Sanna S, Hald M, Arendrup MC, Hjorth SV, Kofoed K. Darier disease complicated by terbinafine-resistant Trichophyton rubrum: a case report. Acta dermato-venereologica. 2017 Jan 1;97(1):139-40.
Digby W, Sanna S, Hald M, Arendrup MC, Hjorth SV, Kofoed K. Darier disease complicated by terbinafine-resistant Trichophyton rubrum: a case report. Acta dermato-venereologica. 2017 Jan 1;97(1):139-40.
Dogra S, Shaw D, Rudramurthy SM. Antifungal drug susceptibility testing of dermatophytes: Laboratory findings to clinical implications. Indian dermatology online journal. 2019 May;10(3):225.
Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: Is the problem deeper than we perceive? Indian Dermatol Online J. 2016;7:73. [PMC free article] [PubMed] [Google Scholar]
Eba M, Njunda AL, Mouliom RN, Kwenti ET, Fuh AN, Nchanji GT, et al. Onychomycosis in diabetic patients in Fako Division of Cameroon: Prevalence, causative agents, associated factors and antifungal sensitivity patterns. BMC Res Notes. 2016;9:1–8. [PMC free article] [PubMed] [Google Scholar].